Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Six months after COVID-19, most patients still had autoantibodies.

TNF-alpha inhibitors can cause various immune-related skin issues.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

B cells can both help and hinder the body's defense against melanoma.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Baicalin may help treat severe drug-induced skin reactions.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.